Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: Potentiation of mitoxantrone cytotoxicity
- 30 April 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 41 (1) , 52-55
- https://doi.org/10.1016/0090-8258(91)90254-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Treatment of advanced ovarian cancer with intraperitoneal tumour necrosis factorEuropean Journal of Cancer and Clinical Oncology, 1990
- Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.Journal of Clinical Oncology, 1990
- Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.Journal of Clinical Oncology, 1990
- Tumour necrosis factor as an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1990
- Therapeutic effect of recombinant human tumor necrosis factor in ovarian carcinoma xenograft in nude miceGynecologic Oncology, 1989
- Human cytokines, tumor necrosis factor, and interferons: Gene cloning, animal studies, and clinical trialsJournal of Cellular Biochemistry, 1988
- Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.The Journal of Immunology, 1987